Life Sciences Workshop: Updates and Recent Trends in Pharmaceutical and Biotechnology Patent Law

Please join us for a discussion of antibody patent prosecution, enforcement, and defense; case law and regulatory updates impacting biosimilar and pharmaceutical products; and recent decisions involving patent-eligible subject matter. Specifically, we will address:

• Antibody patenting in the era of biosimilars, including the shrinking “antibody exception” and how to overcome resistance to such claims, and strategies for expanding the scope of protection
• Recent developments surrounding the Biologics Price Competition and Innovation Act (BPCIA), including recent case law developments, FDA draft guidance for demonstrating biosimilar interchangeability with a reference product, and the intersection with post-grant proceedings before the United States Patent and Trademark Office (USPTO)
• The latest update on Section 101 subject matter eligibility in the life sciences
• Listing patents in the Orange Book: How, when, and why, including the FDA’s new rules and procedures

Speakers: 
Jeffrey M. Jacobstein 
Alissa K. Lipton 
Jill K. MacAlpine, Ph.D. 
Leslie A. McDonell 
Amanda K. Murphy, Ph.D. 
Linda A. Wadler 
Marta Garcia Daneshvar

Date:

Tuesday, May 16, 2017

Time:

8:30 - 9:00 a.m.
Registration and Breakfast

9:00 - 11:45 a.m.
Workshop

11:45 a.m. - 12:30 p.m.
Working Lunch

12:30 - 3:00 p.m.
Workshop

Location: 
Finnegan
Two Seaport Lane
Boston, MA 02210

RSVP: To attend, please register by Friday, May 12, 2017. Space is limited.

Parking: Complimentary parking is available in the Seaport Garage. Please enter through the D Street entrance and bring your parking ticket to the reception area for validation.